| DNA methylation epi-signature is associated with two molecularly and phenotypically distinct clinical subtypes of Phelan-McDermid syndrome LC Schenkel, E Aref-Eshghi, K Rooney, J Kerkhof, MA Levy, H McConkey, ... Clinical epigenetics 13, 1-17, 2021 | 36 | 2021 |
| Neurofibromatosis type 2 in Phelan-McDermid syndrome: Institutional experience and review of the literature CA Ziats, L Jain, B McLarney, E Vandenboom, BR DuPont, C Rogers, ... European Journal of Medical Genetics 63 (11), 104042, 2020 | 17 | 2020 |
| Genetic and metabolic profiling of individuals with Phelan‐McDermid syndrome presenting with seizures L Jain, LM Oberman, L Beamer, L Cascio, M May, S Srikanth, C Skinner, ... Clinical Genetics 101 (1), 87-100, 2022 | 11 | 2022 |
| Position effects of 22q13 rearrangements on candidate genes in Phelan-McDermid syndrome S Srikanth, L Jain, C Zepeda-Mendoza, L Cascio, K Jones, R Pauly, ... PLoS One 16 (7), e0253859, 2021 | 9 | 2021 |
| ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium L Jain, M Khrestian, S Formica, ED Tuason, JA Pillai, S Rao, O Oguh, ... Alzheimer's and Dementia, 2023 | 1 | 2023 |
| AD and ADRD Differences in Luminex and Lumipulse ATN Categories L Jain, M Khrestian, S Formica, ED Tuason, JA Pillai, SM Rao, ... Alzheimer's & Dementia 19, e079993, 2023 | | 2023 |
| Blood-Based Biomarkers 1 TB Murphy, LM Bekris, L Jain, JE Mintzer, AJ Lerner Alzheimer's Association International Conference, 2023 | | 2023 |
| Sleep disturbances in Phelan-McDermid syndrome: Clinical and metabolic profiling of 56 individuals BA Moffitt, LM Oberman, L Beamer, S Srikanth, L Jain, L Cascio, K Jones, ... Clinical Genetics, 1-12, 2023 | | 2023 |
| Cerebrospinal fluid glial fibrillary acidic protein (GFAP) and soluble triggering receptor expressed on myeloid cells 2 (sTREM2) in Alzheimer’s Disease and Related Dementias (ADRD) L Jain, M Khrestian, ED Tuason, JA Pillai, SM Rao, JB Leverenz, ... Alzheimer's & Dementia 18, e068332, 2022 | | 2022 |
| Neurodegenerative Disease Differences in Luminex and Lumipulse ATN Categories L Jain, M Khrestian, S Formica, E Tuason, J Pillai, S Rao, J Leverenz, ... JOURNAL OF MOLECULAR DIAGNOSTICS 24 (10), S132-S132, 2022 | | 2022 |
| Conflict of Interest Statement L Jain CLINICAL AND GENETIC PROFILING IN PHELAN-MCDERMID SYNDROME (PMS), 61, 2021 | | 2021 |
| CHAPTER TWO POSITION EFFECTS OF 22q13 REARRANGEMENTS ON CANDIDATE GENES IN S Srikanth, L Jain, RP Jones, B DuPont, C Rogers, S Sarasua, K Phelan, ... CLINICAL AND GENETIC PROFILING IN PHELAN-MCDERMID SYNDROME (PMS), 19, 2021 | | 2021 |
| Clinical and Genetic Profiling in Phelan-McDermid Syndrome (PMS) L Jain Clemson University, 2021 | | 2021 |
| DNA methylation epi-signature is associated with two molecularly and phenotypically distinct clinical subtypes of Phelan-McDermid syndrome K Phelan, L Jain, N Brunetti-Pierri, B DuPont, SM Sarasua, R Pauly, ... figshare Academic Research System, 2021 | | 2021 |
| Additional file 3 of DNA methylation epi-signature is associated with two molecularly and phenotypically distinct clinical subtypes of Phelan-McDermid syndrome E Aref-Eshghi, MA Levy, L Boccuto, LC Schenkel, J Kerkhof, RC Rogers, ... figshare Academic Research System, 2021 | | 2021 |
Sara Moir SarasuaAssistant Professor, Clemson UniversityGeverifieerd e-mailadres voor g.clemson.edu
